MRC — Mercator Medical SA Income Statement
0.000.00%
- PLN444.55m
- PLN320.16m
- PLN542.49m
- 88
- 93
- 26
- 83
Annual income statement for Mercator Medical SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,834 | 1,727 | 543 | 469 | 542 |
Cost of Revenue | |||||
Gross Profit | 1,151 | 622 | 26.4 | 11.3 | 68.8 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 787 | 1,264 | 724 | 556 | 511 |
Operating Profit | 1,048 | 463 | -181 | -87.1 | 31.1 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1,041 | 477 | -186 | -3.79 | 41.9 |
Provision for Income Taxes | |||||
Net Income After Taxes | 936 | 445 | -191 | -22.8 | 49.8 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 930 | 447 | -190 | -19.7 | 51 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 930 | 447 | -190 | -19.7 | 51 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 88.4 | 45.5 | -20 | -4.03 | 5.14 |
Dividends per Share |